In the SWAN study, menopause was associated with increasing bioavailable T, and declining E2 and sex hormone binding globulin (SHBG) levels.1 The changes in testosterone and SHBG were associated with the MetS and its components. The gene discussed is SHBG; the disease is metabolic syndrome.